Results 291 to 300 of about 3,292,689 (405)

Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). [PDF]

Pituitary
Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF.   +18 more
europepmc   +1 more source

Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.

Endocrine-Related Cancer, 2009
A. Gorshtein, H. Rubinfeld, Efrat Kendler, M. Theodoropoulou, V. Cerovac, G. Stalla, Z. Cohen, M. Hadani, I. Shimon   +8 more
semanticscholar   +1 more source

Exploring Brain Parenchymal Changes in Acromegaly: Focus on White Matter Hyperintensities

Clinical Endocrinology, Volume 104, Issue 3, Page 238-244, March 2026.
ABSTRACT Introduction Acromegaly is a rare chronic disease caused by excessive secretion of growth hormone. Even with biochemical control, hormonal imbalance may lead to cerebral changes. This study aimed to evaluate the presence of white matter hyperintensities (WMHs) in patients with acromegaly.
Denise Costa, Giada Giuliani, Valentina Martines, Chiara Pellicano, Valeria Mercuri, Vittorio Di Piero, Patrizia Gargiulo, Camilla Virili   +7 more
wiley   +1 more source

[Ectopic pituitary tumor of sphenoid sinus: a case report]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Pang Y, Zhu D, Sha J, Zheng J, Yang M, Jin G.   +5 more
europepmc   +1 more source

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti‐Cancer Immunity Across the Lifespan

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos, Esther M. Peluso, Sophia L. Cha, Melissa G. Lechner, Maureen A. Su   +4 more
wiley   +1 more source

PITUITARY TUMOR [PDF]

Southern Medical Journal, 1909
openaire   +1 more source

Russian registry of hypothalamic and pituitary tumors: clinical and statistical analysis for 01.01.2023

Alexander Lutsenko, Elena Przhiyalkovskaya, Olga K. Vikulova, М. А. Исаков, Zhanna Belaya, Liudmila Rozhinskaya, Ekaterina Pigarova, Larisa Dzeranova, Е И Марова, G. А. Melnichenko, Н. М. Платонова, Е. А. Трошина, Н. Г. Мокрышева   +12 more
openalex   +2 more sources

Brain Dose–Volume Thresholds and Survival in Dogs With Intracranial Tumours Treated With the 10 × 4 Gy Radiotherapy Schedule: A Combined Analysis of Two Trials

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 177-185, March 2026.
ABSTRACT Dogs with intracranial tumours routinely receive radiotherapy, yet species‐specific dose–volume constraints for normal brain tissue remain undefined. In human radiation oncology, exceeding certain brain dose–volume thresholds markedly increases the risk of radiation‐induced injury (e.g., radionecrosis).
Sergejs Unterkirhers, Valeria Sabina Meier, Carla Rohrer Bley   +2 more
wiley   +1 more source

A feasibility study of functional preservation in craniospinal irradiation with photon for pediatric medulloblastoma

Journal of Applied Clinical Medical Physics, Volume 27, Issue 2, February 2026.
Abstract Background Craniospinal irradiation (CSI) is essential for treating pediatric medulloblastoma (MB) but causes significant long‐term toxicities. Existing dose‐reduction or partial‐sparing strategies improve neurocognitive outcomes but may compromise survival or fail to address other late effects.
Keqiang Wang, Jie Chen, Jianbo Jian, Peng Wang, Hongyang Zhang, Wenxue Zhang   +5 more
wiley   +1 more source